Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilazodone in Major Depressive Disorder
NCT00290914Phase 2Completed
- Sponsor
- Pharmacology Research Institute
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vilazodone in major depressive disorder (MDD), sponsored by Pharmacology Research Institute. Status: completed.
02
Drugs
vilazodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00290914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290914.